Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIb open-label single-arm study of ABP1011T tablets in unresectable or metastatic osteosarcoma
CTR20254206Phase 2Active
- Sponsor
- EyeBio
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ABP1011T in osteosarcoma (OS), sponsored by EyeBio. Started Nov 2025; status: active.
02
Drugs
ABP1011T
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on CTR20254206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254206.